Adam Stone joined Perceptive Advisors, a hedge fund focused on supporting the progress of the life sciences industry, in 2006.
Over the last decade, Adam helped to grow Perceptive into a multi-billion dollar asset management firm and led the formation of the Perceptive Credit Opportunities Fund. He has played an integral role in the development of several early stage biotech and healthcare companies. Adam is currently serving on the boards of Solid Biosciences and Renovia. Previously, he served as Senior Analyst at Ursus Capital.
Adam earned his BA in molecular biology from Princeton University.